跳至主要内容
临床试验/NCT01223742
NCT01223742已完成不适用

ORAL ACETYL-L-CARNITINE THERAPY REDUCES FATIGUE IN HEPATIC ENCEPHALOPATHY

University of Catania1 个研究点 分布在 1 个国家开始时间: 2002年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
试验地点
1

研究概览

简要总结

The aim of this study was to evaluate the effect of exogenous ALC on the both physical and mental fatigue in mild and moderate encephalopatic patients.

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic hepatitis with spontaneous manifest HE (mental state grade 1 or 2 according to the West Haven criteria) and an NCT-A performance time >30 seconds;
  • Hyperammonemia (venous ammonia concentration >50 mmol/L);
  • Cooperative, hospitalised, adult patients with liver cirrhosis diagnosed by clinical, histological and ultrasonographic findings (reduced dimensions of the liver as well as splenomegaly) and oesophageal varices at stage II and III observed by endoscopy.

排除标准

  • Major complications of portal hypertension, such as gastrointestinal blood loss, hepatorenal syndrome or bacterial peritonitis;
  • Acute superimposed liver injury;
  • Patient with other neurological disease and metabolic disorders, diabetes mellitus, unbalanced heart failure and/or respiratory failure or end-stage renal disease;
  • Alcoholic -toxic cirrhosis because toxic brain damage may interfere with the assessment of HE;
  • Severe HE;
  • Administration of anti-HE medications such as neomycin, branched-chain amino acids;
  • Any additional precipitating factors such as high protein intake (additional high-protein meals), constipation or intake of psycho stimulants, sedatives, antidepressants, benzodiazepines, or benzodiazepines-antagonists (flumazenil), beta-adrenergic blockers, neuromuscular blocking agents, certain antibiotics;
  • Patients with fever, sepsis or shock were also excluded to avoid variations caused by body temperature;
  • Illiteracy.

研究组 & 干预措施

ACETYL-L-CARNITINE

Experimental

干预措施: ACETYL-L-CARNITINE (Dietary Supplement)

placebo

Placebo Comparator

干预措施: placebo (Drug)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验